Peterson Chelsea, Denlinger Nathan, Yang Yiping
Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Cancers (Basel). 2022 Aug 17;14(16):3972. doi: 10.3390/cancers14163972.
Cancer immunotherapy has revolutionized the field of oncology in recent years. Harnessing the immune system to treat cancer has led to a large growth in the number of novel immunotherapeutic strategies, including immune checkpoint inhibition, chimeric antigen receptor T-cell therapy and cancer vaccination. In this review, we will discuss the current landscape of immuno-oncology research, with a focus on elements that influence immunotherapeutic outcomes. We will also highlight recent advances in basic aspects of tumor immunology, in particular, the role of the immunosuppressive cells within the tumor microenvironment in regulating antitumor immunity. Lastly, we will discuss how the understanding of basic tumor immunology can lead to the development of new immunotherapeutic strategies.
近年来,癌症免疫疗法彻底改变了肿瘤学领域。利用免疫系统治疗癌症已促使新型免疫治疗策略的数量大幅增长,包括免疫检查点抑制、嵌合抗原受体T细胞疗法和癌症疫苗接种。在本综述中,我们将讨论免疫肿瘤学研究的现状,重点关注影响免疫治疗结果的因素。我们还将强调肿瘤免疫学基础方面的最新进展,特别是肿瘤微环境中免疫抑制细胞在调节抗肿瘤免疫中的作用。最后,我们将讨论对基础肿瘤免疫学的理解如何能够推动新免疫治疗策略的发展。